Department of Critical Care Medicine, Chun'an First People's Hospital (Zhejiang Provincial People's Hospital Chun'an Branch), Hangzhou 311700, Zhejiang Province, China.
Department of Critical Care Medicine, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou 310014, Zhejiang Province, China.
Int Immunopharmacol. 2018 Sep;62:287-292. doi: 10.1016/j.intimp.2018.07.024. Epub 2018 Jul 23.
Sepsis is a major cause of mortality among critically ill patients in the intensive care unit (ICU). Alterations in serum amyloid A (SAA) and nitric oxide (NO) levels have been associated with mortality in critically ill patients. In the present study, we investigated the predictive value of SAA and/or NO compared to traditional predictive markers such as C-reactive protein (CRP) and Acute Physiology and Chronic Health Evaluation II (APACHE II) score.
100 adult patients with sepsis and 25 without sepsis were enrolled in a prospective, randomized study in our ICU. The APACHE II score was calculated, and their peripheral venous blood SAA, NO and CRP levels were evaluated on days 1, 3, and 7 after sepsis was diagnosed. The patients were sorted based on incidence of septic shock into septic shock (A) and non-septic shock (B) groups. Comparative analyses of altered levels of these indicators between the two groups were performed, and correlations between SAA, NO, and the more traditional APACHE II score were probed. Patients were sorted based on survival status into death (D) and survival (S) groups based on death endpoint within 28 days after admission.
We observed that the difference in APACHE II score, SAA and CRP levels were statistically significantly (p < 0.05) between groups A and B on days 1, 3 and 7 post-diagnosis, while inter-group NO level significantly differed (p < 0.05) on days 1 and 3 post-diagnosis, no apparent difference was observed on day 7 post-diagnosis. For groups D and S, SAA, CRP and NO levels significantly differed (p < 0.05) on days 3 and 7 post-diagnosis, with no apparent difference on day 1. APACHE II score was significantly different on day 7 (p < 0.05), however the difference on days 1 and 3 were non-significant. We also demonstrated a positive correlation between APACHE II scores, SAA levels on days 1, 3, and 7, as well as NO levels on days 1 and 3. In addition, for the D and S groups, SAA at all time points, NO on day 3 and CRP on day 7 positively correlated with increased death events.
The dynamic monitoring of SAA and NO serum levels with APACHE II scores better reflect the severity of sepsis than traditional indicators like CRP and may serve as independent prognosticators of sepsis in critically ill patients, shorten time to diagnosis confirmation and improve therapeutic decision-making.
脓毒症是重症监护病房(ICU)中危重病患者死亡的主要原因。血清淀粉样蛋白 A(SAA)和一氧化氮(NO)水平的改变与危重病患者的死亡率有关。本研究旨在探讨 SAA 和/或 NO 与传统预测标志物如 C 反应蛋白(CRP)和急性生理学和慢性健康评估 II (APACHE II)评分相比的预测价值。
本研究纳入了 100 例脓毒症患者和 25 例非脓毒症患者,前瞻性、随机纳入 ICU 患者。计算 APACHE II 评分,并在脓毒症诊断后第 1、3、7 天评估其外周静脉血 SAA、NO 和 CRP 水平。根据是否发生感染性休克将患者分为感染性休克(A)组和非感染性休克(B)组。比较两组这些指标水平的变化,探讨 SAA、NO 与更传统的 APACHE II 评分之间的相关性。根据 28 天内死亡终点,将患者分为死亡(D)和存活(S)组。
我们观察到,在诊断后第 1、3、7 天,A 组和 B 组之间的 APACHE II 评分、SAA 和 CRP 水平差异具有统计学意义(p<0.05),而在第 1 和第 3 天,组间 NO 水平差异具有统计学意义(p<0.05),第 7 天无明显差异。对于 D 组和 S 组,SAA、CRP 和 NO 水平在第 3 和第 7 天差异具有统计学意义(p<0.05),第 1 天无明显差异。APACHE II 评分在第 7 天差异具有统计学意义(p<0.05),第 1 和第 3 天无明显差异。我们还发现,APACHE II 评分与第 1、3、7 天的 SAA 水平以及第 1 和第 3 天的 NO 水平呈正相关。此外,对于 D 组和 S 组,所有时间点的 SAA、第 3 天的 NO 和第 7 天的 CRP 与死亡事件的增加呈正相关。
与 CRP 等传统指标相比,动态监测 SAA 和 NO 血清水平与 APACHE II 评分能更好地反映脓毒症的严重程度,可能成为危重症患者脓毒症的独立预后指标,缩短确诊时间,改善治疗决策。